2012 ©
             Publication
Journal Publication
Research Title Effects of Erythrosine With/out Nano-TiO2 Dioxide-Mediated Photodynamic Therapy On HGF-1 and HOK Cells By PrestoBlue® Viability Assay 
Date of Distribution 16 August 2018 
Conference
     Title of the Conference การประชมุ นาเสนอผลงานวจิ ัยระดับบณั ฑิตศึกษา ครงั้ ที่ ๑๓ปี การศึกษา ๒๕๖๑ 
     Organiser มหาวิทยาลัยรังสิต 
     Conference Place มหาวิทยาลัยรังสิต 
     Province/State กรุงเทพมหานคร 
     Conference Date 16 August 2018 
     To 16 August 2018 
Proceeding Paper
     Volume 13 
     Issue 13 
     Page 3100-3111 
     Editors/edition/publisher บรรณาธิการ มหาวิทยาลัยรังสิต 
     Abstract The photodynamic therapy (PDT) is an alternative treatment for localized target tissue (e.g. tumors, cancers, etc.) that mainly results in target cell death in oxidation mechanism in producing reactive oxygen species (ROS). Erythrosine dye, not only is known as a standard disclosing agent in Dentistry, with its photosensitizer (PS) property, it also has been used as an antimicrobial PS. However, the cell viability of normal human oral cells of Erythrosine dye tested with Nano-titanium dioxide (Nano-TiO2) which is widely utilized as a photo-catalyst in order to enhance a photodynamic reaction still has been unknown. Objectives: To study the effects of Erythrosine with/out Nano-TiO2 as a photosensitizer on viability and morphology of normal human gingival fibroblast cell line (ATCC® CRL-2014, HGF-1) and Primary Human Oral Keratinocytes; HOK (ATCC® PCS200­014TM) primary cells. Methods: Eleven test groups of each HGF-1 and HOK were tested by Erythrosine as a photosensitizer in different concentration namely, Erythrosine (Ery) at 0 μM, 55 μM, 110 μM, 220 μM, and 440 μM in the presence and/or absence of 1% w/w Nano-TiO2 with blue light, Nano-TiO2 alone, and control groups (positive control = DMEM, abd negative control = H2O2). With LED-dental curing light (BA Optima 10, 420-480 nm, 16-19 J/cm2) for 1 min, at 1, 6, or 24 hrs, cell viability assays using PrestoBlue® (Invitrogen, Life Technologies GmbH, Darmstadt Germany) with VarioskanTM at excitation/emission wavelength 560/590 nm. Cell morphology was investigated by SEM (S3000N, Hitashi, Japan). Results: The difference between HGF-1 and HOK cell viability in Erythrosine-Nano-titamium dioxide-mediated photodynamic therapy was not statistically significant (p-value < 0.05) among the groups at all-time point, except for Erythrosine 440 μM that significantly reduced cell viability observed at 24 hrs. by utilizing one-way ANOVA and post hoc test. Furthermore, some morphology changes were observed between test and control groups by SEM. Conclusions: Erythrosine with Nano-TiO2, a novel PDT photosensitizer in the range of the present study exerted no toxicity on HGF-1 and HOK cells. 
Author
575130011-7 Miss JIRAYU ANANTAWAN [Main Author]
Dentistry Master's Degree

Peer Review Status มีผู้ประเมินอิสระ 
Level of Conference ชาติ 
Type of Proceeding Full paper 
Type of Presentation Poster 
Part of thesis true 
Presentation awarding false 
Attach file
Citation 15